MLchartDataset catalogue

carcinoembryonic antigen peptide 1-6D virus-like replicon particles vaccine

Term · Oncology and biomedicine · MLC-T-ONC-012304

A cancer vaccine, consisting of alphavirus vector-derived virus-like replicon particles expressing the 9-amino-acid carcinoembryonic antigen peptide (CAP) 1-6D, with potential antineoplastic activity. Vaccination with this agent may elicit a cytotoxic T lymphocyte (CTL) immune response against CEA-expressing tumor cells.

Table 1. Record
IdentifierMLC-T-ONC-012304
FieldOncology and biomedicine
AbbreviationCEA(6D) VRP vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012304",
  "term": "carcinoembryonic antigen peptide 1-6D virus-like replicon particles vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine, consisting of alphavirus vector-derived virus-like replicon particles expressing the 9-amino-acid carcinoembryonic antigen peptide (CAP) 1-6D, with potential antineoplastic activity. Vaccination with this agent may elicit a cytotoxic T lymphocyte (CTL) immune response against CEA-expressing tumor cells.",
  "abbreviation": "CEA(6D) VRP vaccine",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/carcinoembryonic-antigen-peptide-1-6d-virus-like-replicon-particles-vaccine/"
}

Record 4,220 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.